Lpl Financial LLC Brainstorm Cell Therapeutics Inc. Transaction History

Lpl Financial LLC

  • $218 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024
BUY
$0.34 - $0.74 $3,417 - $7,438
10,052 New
10,052 $3,000
Q3 2023

Nov 13, 2023
SELL
$0.2 - $2.08 $20 - $208
-100 Reduced 0.24%
41,441 $8,000
Q2 2023

Jul 31, 2023
BUY
$2.0 - $3.2 $83,082 - $132,931
41,541 New
41,541 $85,000

Others Institutions Holding BCLI

# of Institutions
42
Shares Held
10.9M
Call Options Held
160K
Put Options Held
30.5K
View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

BCLI Quotes by TradingView
  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $39.4M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email